April 08, 2018

Omnicell Appoints Scott Seidelmann as Chief Commercial Officer

Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced that Scott Seidelmann has joined the Company as Chief Commercial Officer beginning this month. Mr. Seidelmann is responsible for the commercial strategy for the company, bringing more than 20 years of experience in leading growth businesses that drive customer success.

“With the evolving complexities of healthcare consolidation, we must leverage emerging digital health technologies to help our customers succeed in an ever-changing healthcare environment,” said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. “Scott brings unique capabilities that will accelerate our efforts in the new digital health world and allow us to meet customer needs and expand our business.”

Prior to joining Omnicell, Mr. Seidelmann was the founder and CEO of Candescent Health, a cloud-based radiology workflow and analytics provider. He was previously co-founder and CEO of Radisphere Inc., one of the largest radiology practices in the U.S., which leveraged technology and analytics to transform the radiology care delivery model. Earlier in his career, Mr. Seidelmann held positions with Merrill Lynch and Ericsson Venture Partners, a technology venture capital firm.

“Drug distribution and pharmacy are large and meaningful areas of healthcare and are ripe for innovation and transformation,” said Mr. Seidelmann. “My expertise and passion lies in applying technology to improve care delivery and building high-functioning, collaborative teams that make improved care a reality. I look forward to leading Omnicell’s global strategy to align with our evolving customers and create safer and more efficient ways to manage patient care across healthcare settings, from hospital to home.”

omnicell closing icon